Fate Therapeutics, Inc.

FATE·NasdaqGM·Healthcare

FollowCompareShare

2.1800+0.0500 (+2.35%)today

At close: Oct 9, 4:00 PM EDT · Real-time · USD

After hours2.1700−0.0100 (−0.46%)Oct 9, 6:45 PM EDT

1D5D1M6MYTD1Y5YMAX

MountainLineCandles

Indicators

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.1300

Open2.1300

Day range2.10002.2750

52-week range0.95003.2300

Volume770.69K

Avg. volume (3M)1.77M

Market cap261.21M

P/E ratio (TTM)—

Forward P/E-2.25

EPS (TTM)-1.05

Dividend yield—

Beta (5Y)2.53

Shares outstanding119.82M

Earnings dateAug 13, 2026 (est.)

Analyst target5.7444

Profit margin0.00%

Latest news

All FATE news ›

MarketBeat·1d ago

Fate Therapeutics, Inc. (NASDAQ:FATE) Stock Has Consensus Target Price of $5.90

Get Our Latest Analysis on Fate Therapeutics Shares of NASDAQ FATE opened at $2.13 on Friday. The stock has a market cap of $255.22 million, a PE ratio of -2.03 and a beta of 2.52. Fate Therapeutics has a 1 year low of $0.95 and a 1 year…

MarketScreener·3d ago

TruAge(R) Age-Verification Solution Integrated Across NCR Voyix Point-of-Sale Portfolio for Convenience and Fuel Retailers

Published on 10/07/2026 at 09:47 am EDT TruAge allows retailers to verify age, identify fake or expired IDs and check purchase limits by scanning a physical or digital driver's license. The solution uses secure, anonymized tokens to…

The Manila Times·Oct 2

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular…

The Manila Times·Oct 1

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

manilatimes.net SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived…

From articles in the 4Search news index.

In the news

6mentions in 30 days

4with it in the headline

Mixedheadline tone

Mentioned with

Instagram3U.S. Food and Drug Administration3YouTube3Cantor Global Healthcare Conference2Cybin Inc.2Goldman Sachs 47Th Annual Global Healthcare2Helus Pharma2Helus Pharma Corp2

People in the coverage

Laura Hamill3Adrian Gottschalk2Amanda Lazaro2Annie J. Cheng2Brent Pfeiffenberger2Fitzgerald2

Themes

Healthcare3Reports3Therapeutics3Events2Financial2Quarter2Results2Second2

Most coverage from

1. manilatimes.net3
2. ggbmagazine.com1
3. marketbeat.com1
4. marketscreener.com1

Measured across the 4Rochester news index. Headline tone is a simple word-based reading of the latest 6 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Rochester index. Terms of use.